Literature DB >> 10894357

Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease.

S Morecki1, S Slavin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10894357     DOI： 10.1089/15258160050079461

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN： 1525-8165


× No keyword cloud information.
  2 in total

1.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Nonmyeloablative stem cell transplantation as immunotherapy for kidney cancer and other metastatic solid tumors.

Authors:  Cristian Carvallo; Richard Childs
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.